1.17
-0.01(-0.85%)
Currency In USD
| Previous Close | 1.18 |
| Open | 1.19 |
| Day High | 1.2 |
| Day Low | 1.16 |
| 52-Week High | 2.04 |
| 52-Week Low | 1.11 |
| Volume | 906,639 |
| Average Volume | 3.23M |
| Market Cap | 898.21M |
| PE | -4.87 |
| EPS | -0.24 |
| Moving Average 50 Days | 1.29 |
| Moving Average 200 Days | 1.35 |
| Change | -0.01 |
If you invested $1000 in OPKO Health, Inc. (OPK) 10 years ago, it would be worth $125.67 as of February 26, 2026 at a share price of $1.17. Whereas If you bought $1000 worth of OPKO Health, Inc. (OPK) shares 5 years ago, it would be worth $260 as of February 26, 2026 at a share price of $1.17.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26
GlobeNewswire Inc.
Feb 12, 2026 1:00 PM GMT
MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on Thursday, February 26, 20
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
GlobeNewswire Inc.
Feb 04, 2026 1:00 PM GMT
This is the third program that successfully combines Entera’s oral peptide N-Tab® platform with OPKO’s advanced protein chemistry capabilities The companies have accelerated this program and aim to file an investigational new drug (IND) application i
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 06, 2026 9:11 PM GMT
MIAMI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 44th Annual J.P. Morgan Healthcare Conference, being held January 12-15, 2026, at the Westin St. Francis Hotel in